A reduction in tumor-promoting macrophage markers such as Arginase 1 (Arg 1) and CCL2 [67] was also observed in BMDMs stimulated with conditioned media from pancreatic cancer cells and treated with I-BET-762 (Supplementary Figure S1D). This evidence concerns the gene CCL2 and familial pancreatic carcinoma.